A Real-World Prospective Study of Comprehensive Genomic Testing in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer · Published 2025-01-01 · Journal article · DOI 10.1016/j.clgc.2026.102570

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clgc.2026.102570

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies · Clinical Genitourinary Cancer · 2026 · Same journal
• The Utility of the Comprehensive Complication Index in Demonstrating the Complication Burden and Predicting Length of Stay in Robot-Assisted Radical Prostatectomy · Clinical Genitourinary Cancer · 2026 · Same journal
• Real-World Effectiveness and Tolerability of Belzutifan in Sporadic Clear Cell Renal Cell Carcinoma: A Retrospective Cohort Study With Exploratory Genomic Correlation · Clinical Genitourinary Cancer · 2026 · Same journal
• Exploration of the Challenges in the Management of Prostate Cancer in East Africa · Clinical Genitourinary Cancer · 2025 · Same journal
• Real-World Treatment Duration With First-line Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Cancer: A National Electronic Health Record Study · Clinical Genitourinary Cancer · 2026 · Same journal
• Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications—A Systematic Review · Clinical Genitourinary Cancer · 2026 · Same journal
• Impact of Age on Outcomes in Metastatic Non–Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT) · Clinical Genitourinary Cancer · 2026 · Same journal
• Efficacy and Safety of Every Other Week Gemcitabine and Docetaxel (GEMDOC) in Heavily Pretreated Metastatic Castration Resistant Prostate Cancer: A Retrospective Real-world Analysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules · Clinical Genitourinary Cancer · 2025 · Same journal
• Why Has Prostate Cancer Research Lagged Behind? Advocacy, Biology, and the Road Ahead · Clinical Genitourinary Cancer · 2026 · Same journal